Now
We’re building on decades of global vaccine experience to help protect Australians against certain vaccine-preventable diseases.
MSD is committed to helping protect public health and to the discovery, development and distribution of our vaccines across Australia and around the world. To do so, we are focusing on six key areas:
Global Research and Development (R&D)
We invested US$30.5B in R&D across all medicines and vaccines in 2023.1
Clinical Research
We’re investing in new research technologies involving Australian clinicians, as well as supporting clinical trials and independent clinical research.
Healthcare Professional Education and Awareness
We’re committed to educating healthcare professionals to ensure they are up to date with the latest information on our vaccines.
Supply Chain and Logistics
We have an established network of suppliers for cold chain logistics.
Global Manufacturing
We have consistent and reliable manufacturing capabilities across the world.
Regulatory and Quality
Our experienced team works with Australia’s regulatory authority and Department of Health and Aged Care to help ensure our vaccines reach Australians.
Reference: 1. MSD, Data on file.
AU-NON-00613 v3. Issued December 2024.